Jeuveau® is the most precise neurotoxin available. It acts like the other leading neurotoxins but is long lasting and has a short "therapeutic window" quick onset of action. It is proven effective in as little as 2 days and as long as 4 months.
Jeuveau® puts control of fast-acting, long-lasting intramuscular results in the hands of the provider. After 30 days, over 94% of patients said they felt "much improved" or "improved," and you know what: numbers don't lie.
70% of U.S. patients using Jeuveau® saw a 2-grade or better improvement in frown lines after 30 days. Get deeper quarterly discounts and more marketing benefits. We are pleased to announce that we now offer Jeuveau®, by Evolus, at extremely low prices for MedResults Network members through our partnership with Pipeline Medical.
FDA-approved 900-kDa neurotoxin; Jeuveau® has proven its efficacy for desired results. The modern-made neurotoxin was released in 2019 to reduce wrinkles proved by studies on over 2,100 subjects in 5 clinical trials.
(EV 001) for Jeuveau®
Only 1.2% of patients showed positive results in the placebo group compared to Jeuveau® where 67.5% showed results.
(EV002) for Jeuveau®
Only 1.3% of patients showed positive results in the placebo arm compared to the Jeuveau® group 70% showed results.